Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil switch study after memantine monotherapy discontinuation in Alzheimer's disease
2004-004918-17Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of donepezil in Alzheimer's disease (AD), sponsored by Pfizer. Primary endpoint: Mini Mental State Examination (MMSE). Started Feb 2005; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2004-004918-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004918-17.